This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Mar 3;281(9):841-4.

doi: 10.1001/jama.281.9.841.

Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance

R Temple¹

Affiliations

PMID: 10071007
DOI: 10.1001/jama.281.9.841

Comment

Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance

R Temple. JAMA. 1999.

. 1999 Mar 3;281(9):841-4.

doi: 10.1001/jama.281.9.841.

Author

R Temple¹

Affiliation

¹ Center for Drug Evaluation & Research, Food and Drug Administration, Rockville, MD 20857, USA.

PMID: 10071007
DOI: 10.1001/jama.281.9.841

No abstract available

PubMed Disclaimer

Comment in

Higher standards for epidemiologic studies--replication prior to publication?
Weed DL. Weed DL. JAMA. 1999 Sep 8;282(10):937-8. doi: 10.1001/jama.282.10.937. JAMA. 1999. PMID: 10485668 No abstract available.

Comment on

Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.
Brewer T, Colditz GA. Brewer T, et al. JAMA. 1999 Mar 3;281(9):824-9. doi: 10.1001/jama.281.9.824. JAMA. 1999. PMID: 10071004
The role of meta-analysis in the regulatory process for foods, drugs, and devices.
Berlin JA, Colditz GA. Berlin JA, et al. JAMA. 1999 Mar 3;281(9):830-4. doi: 10.1001/jama.281.9.830. JAMA. 1999. PMID: 10071005

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems